Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The myeloid cell nuclear differentiation antigen (MNDA) is detected only in nuclei of cells of the granulocyte-monocyte lineage. Additionally we are shipping MNDA Proteins (14) and MNDA Kits (3) and many more products for this protein.
Showing 10 out of 61 products:
Human Monoclonal MNDA Primary Antibody for FACS, IF - ABIN1108273
Murphy: Cytomics and location proteomics: automated interpretation of subcellular patterns in fluorescence microscope images. in Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005
Show all 12 references for ABIN1108273
Human Monoclonal MNDA Primary Antibody for FACS, IF - ABIN1108272
Quesenberry, Abedi, Aliotta, Colvin, Demers, Dooner, Greer, Hebert, Menon, Pimentel, Paggioli: Stem cell plasticity: an overview. in Blood cells, molecules & diseases 2004
Show all 12 references for ABIN1108272
Human Polyclonal MNDA Primary Antibody for EIA, FACS - ABIN953470
Kimkong, Avihingsanon, Hirankarn: Association of IFI200 gene polymorphisms with susceptibility to systemic lupus erythematosus. in The Journal of rheumatology 2010
Show all 2 references for ABIN953470
Human Polyclonal MNDA Primary Antibody for WB - ABIN2780426
Briggs, Shults, Flye, McClintock-Treep, Jagasia, Goodman, Boulos, Jacobberger, Stelzer, Head: Dysregulated human myeloid nuclear differentiation antigen expression in myelodysplastic syndromes: evidence for a role in apoptosis. in Cancer research 2006
MNDA expression is an independent marker for the evaluation of dyspoiesis and may be added to the standard panel for quantitative assessment by FCM (show NOL3 Antibodies).
Studied the HIN domain of recombinant myeloid nuclear differentiation antigen (MNDA).
these data support the inclusion of MNDA in the diagnostic evaluation of extramedullary B-cell lymphomas, particularly those in which the differential diagnosis is between low-grade follicular lymphoma and marginal zone lymphoma.
Retroviral mediated expression of the human myeloid nuclear antigen in a null cell line upregulates Dlk1 (show DLK1 Antibodies) expression
variation in MNDA expression appeared to change with phenotypic specialization of monocytes in atherosclerosis consistent with its association with inflammation and suspected roles in regulating gene expression or in mediating cell death
MNDA has a role regulating programmed cell death in myeloid progenitor cells, and that its down-regulation in myelodysplastic syndromes is related to granulocyte-macrophage progenitor cell sensitivity to TRAIL-induced programmed cell death.
MNDA expression is a useful tool for the recognition of nodal marginal zone lymphoma
The role of Mnda in response to apoptosis and genotoxic stress is discussed.
The myeloid cell nuclear differentiation antigen (MNDA) is detected only in nuclei of cells of the granulocyte-monocyte lineage. A 200-amino acid region of human MNDA is strikingly similar to a region in the proteins encoded by a family of interferon-inducible mouse genes, designated Ifi-201, Ifi-202, and Ifi-203, that are not regulated in a cell- or tissue-specific fashion. The 1.8-kb MNDA mRNA, which contains an interferon-stimulated response element in the 5-prime untranslated region, was significantly upregulated in human monocytes exposed to interferon alpha. MNDA is located within 2,200 kb of FCER1A, APCS, CRP, and SPTA1. In its pattern of expression and/or regulation, MNDA resembles IFI16, suggesting that these genes participate in blood cell-specific responses to interferons.
, interferon activated
, interferon-activable protein 205-B
, interferon-inducible protein p205-B
, protein D3